Product news

Teva said the FDA approved its generic version of Procter & Gamble Actonel (risedronate sodium tablets) in 5 mg, 30 mg and 35 mg doses to treat and prevent postmenopausal and glucocorticoid-induced osteoporosis, and to treat Paget's disease. Actonel had US sales of about $1 billion, for the 12 months ended June 30, based on IMS sales data.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.